These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33630555)

  • 1. Structural MRI for the Early Diagnosis of Alzheimer Disease in Patients with MCI.
    Butler E; Mounsey A
    Am Fam Physician; 2021 Mar; 103(5):273-274. PubMed ID: 33630555
    [No Abstract]   [Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging texture predicts progression to dementia due to Alzheimer disease earlier than hippocampal volume.
    Lee S; Lee H; Kim KW;
    J Psychiatry Neurosci; 2020 Jan; 45(1):7-14. PubMed ID: 31228173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
    Piersson AD; Ibrahim B; Suppiah S; Mohamad M; Hassan HA; Omar NF; Ibrahim MI; Yusoff AN; Ibrahim N; Saripan MI; Razali RM
    PLoS One; 2021; 16(9):e0252883. PubMed ID: 34547018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for early diagnosis of Alzheimer's disease based on pseudo Zernike moment from structural MRI.
    Gorji HT; Haddadnia J
    Neuroscience; 2015 Oct; 305():361-71. PubMed ID: 26265552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3D densely connected convolution neural network with connection-wise attention mechanism for Alzheimer's disease classification.
    Zhang J; Zheng B; Gao A; Feng X; Liang D; Long X
    Magn Reson Imaging; 2021 May; 78():119-126. PubMed ID: 33588019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting conversion from MCI to AD by integrating rs-fMRI and structural MRI.
    Hojjati SH; Ebrahimzadeh A; Khazaee A; Babajani-Feremi A;
    Comput Biol Med; 2018 Nov; 102():30-39. PubMed ID: 30245275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural correlates of mild cognitive impairment: A clinicovolumetric study.
    Sheelakumari R; Kesavadas C; Lekha VS; Justus S; Sarma PS; Menon R
    Neurol India; 2018; 66(2):370-376. PubMed ID: 29547157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.
    Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H
    J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
    Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
    J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric computer-aided differential diagnosis of Alzheimer's disease and frontotemporal dementia using structural and advanced MRI.
    Bron EE; Smits M; Papma JM; Steketee RME; Meijboom R; de Groot M; van Swieten JC; Niessen WJ; Klein S
    Eur Radiol; 2017 Aug; 27(8):3372-3382. PubMed ID: 27986990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
    Ferrari BL; Neto GCC; Nucci MP; Mamani JB; Lacerda SS; Felício AC; Amaro E; Gamarra LF
    Medicine (Baltimore); 2019 Nov; 98(45):e17824. PubMed ID: 31702636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.
    Monge Argilés JA; Blanco Cantó MA; Leiva Salinas C; Flors L; Muñoz Ruiz C; Sánchez Payá J; Gasparini Berenguer R; Leiva Santana C
    Neurologia; 2014 Sep; 29(7):397-401. PubMed ID: 23969296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI Radiomics Classification and Prediction in Alzheimer's Disease and Mild Cognitive Impairment: A Review.
    Feng Q; Ding Z
    Curr Alzheimer Res; 2020; 17(3):297-309. PubMed ID: 32124697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
    Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging in Stable Mild Cognitive Impairment, Prodromal Alzheimer's Disease, and Prodromal Dementia with Lewy Bodies.
    Siddiqui TG; Whitfield T; Praharaju SJ; Sadiq D; Kazmi H; Ben-Joseph A; Walker Z
    Dement Geriatr Cogn Disord; 2020; 49(6):583-588. PubMed ID: 33227783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contourlet-based hippocampal magnetic resonance imaging texture features for multivariant classification and prediction of Alzheimer's disease.
    Gao N; Tao LX; Huang J; Zhang F; Li X; O'Sullivan F; Chen SP; Tian SJ; Mahara G; Luo YX; Gao Q; Liu XT; Wang W; Liang ZG; Guo XH
    Metab Brain Dis; 2018 Dec; 33(6):1899-1909. PubMed ID: 30178281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.